Cancer Biomarkers Market Report

Japan Cancer Biomarkers Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Mar 12, 2020
  • PAGES：163
  • REPORT CODE：GMM503929
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Cancer Biomarkers market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Cancer Biomarkers market. Detailed analysis of key players, along with key growth strategies adopted by Cancer Biomarkers industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Agilent Technologies

    • Novartis AG

    • Abbott Laboratories

    • BioMerieux SA

    • Qiagen NV

    By Type:

    • Protein Biomarkers

    • Genetic Biomarkers

    • Others

    By End-User:

    • Breast Cancer

    • Lung Cancer

    • Colorectal Cancer

    • Melanoma

    • Blood Cancer

    • Prostate Cancer

    • Ovarian Cancer

    • Stomach Cancer

    • Liver Cancer

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Biomarkers Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Cancer Biomarkers Market Size and Growth Rate of Protein Biomarkers from 2014 to 2026

      • 1.3.2 Japan Cancer Biomarkers Market Size and Growth Rate of Genetic Biomarkers from 2014 to 2026

      • 1.3.3 Japan Cancer Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Cancer Biomarkers Market Size and Growth Rate of Breast Cancer from 2014 to 2026

      • 1.4.2 Japan Cancer Biomarkers Market Size and Growth Rate of Lung Cancer from 2014 to 2026

      • 1.4.3 Japan Cancer Biomarkers Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

      • 1.4.4 Japan Cancer Biomarkers Market Size and Growth Rate of Melanoma from 2014 to 2026

      • 1.4.5 Japan Cancer Biomarkers Market Size and Growth Rate of Blood Cancer from 2014 to 2026

      • 1.4.6 Japan Cancer Biomarkers Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

      • 1.4.7 Japan Cancer Biomarkers Market Size and Growth Rate of Ovarian Cancer from 2014 to 2026

      • 1.4.8 Japan Cancer Biomarkers Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

      • 1.4.9 Japan Cancer Biomarkers Market Size and Growth Rate of Liver Cancer from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cancer Biomarkers Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cancer Biomarkers by Major Types

      • 3.4.1 Market Size and Growth Rate of Protein Biomarkers

      • 3.4.2 Market Size and Growth Rate of Genetic Biomarkers

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Cancer Biomarkers Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cancer Biomarkers by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Cancer Biomarkers in Breast Cancer

      • 4.4.2 Market Size and Growth Rate of Cancer Biomarkers in Lung Cancer

      • 4.4.3 Market Size and Growth Rate of Cancer Biomarkers in Colorectal Cancer

      • 4.4.4 Market Size and Growth Rate of Cancer Biomarkers in Melanoma

      • 4.4.5 Market Size and Growth Rate of Cancer Biomarkers in Blood Cancer

      • 4.4.6 Market Size and Growth Rate of Cancer Biomarkers in Prostate Cancer

      • 4.4.7 Market Size and Growth Rate of Cancer Biomarkers in Ovarian Cancer

      • 4.4.8 Market Size and Growth Rate of Cancer Biomarkers in Stomach Cancer

      • 4.4.9 Market Size and Growth Rate of Cancer Biomarkers in Liver Cancer

    5 Market Analysis by Regions

    • 5.1 Japan Cancer Biomarkers Production Analysis by Regions

    • 5.2 Japan Cancer Biomarkers Consumption Analysis by Regions

    6 Hokkaido Cancer Biomarkers Landscape Analysis

    • 6.1 Hokkaido Cancer Biomarkers Landscape Analysis by Major Types

    • 6.2 Hokkaido Cancer Biomarkers Landscape Analysis by Major End-Users

    7 Tohoku Cancer Biomarkers Landscape Analysis

    • 7.1 Tohoku Cancer Biomarkers Landscape Analysis by Major Types

    • 7.2 Tohoku Cancer Biomarkers Landscape Analysis by Major End-Users

    8 Kanto Cancer Biomarkers Landscape Analysis

    • 8.1 Kanto Cancer Biomarkers Landscape Analysis by Major Types

    • 8.2 Kanto Cancer Biomarkers Landscape Analysis by Major End-Users

    9 Chubu Cancer Biomarkers Landscape Analysis

    • 9.1 Chubu Cancer Biomarkers Landscape Analysis by Major Types

    • 9.2 Chubu Cancer Biomarkers Landscape Analysis by Major End-Users

    10 Kinki Cancer Biomarkers Landscape Analysis

    • 10.1 Kinki Cancer Biomarkers Landscape Analysis by Major Types

    • 10.2 Kinki Cancer Biomarkers Landscape Analysis by Major End-Users

    11 Chugoku Cancer Biomarkers Landscape Analysis

    • 11.1 Chugoku Cancer Biomarkers Landscape Analysis by Major Types

    • 11.2 Chugoku Cancer Biomarkers Landscape Analysis by Major End-Users

    12 Shikoku Cancer Biomarkers Landscape Analysis

    • 12.1 Shikoku Cancer Biomarkers Landscape Analysis by Major Types

    • 12.2 Shikoku Cancer Biomarkers Landscape Analysis by Major End-Users

    13 Kyushu Cancer Biomarkers Landscape Analysis

    • 13.1 Kyushu Cancer Biomarkers Landscape Analysis by Major Types

    • 13.2 Kyushu Cancer Biomarkers Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Agilent Technologies

      • 14.1.1 Agilent Technologies Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Novartis AG

      • 14.2.1 Novartis AG Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Abbott Laboratories

      • 14.3.1 Abbott Laboratories Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 BioMerieux SA

      • 14.4.1 BioMerieux SA Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Qiagen NV

      • 14.5.1 Qiagen NV Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 109 Figures and 187 Tables)

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Protein Biomarkers from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Genetic Biomarkers from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Lung Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Melanoma from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Blood Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Ovarian Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Liver Cancer from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Cancer Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cancer Biomarkers Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cancer Biomarkers

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cancer Biomarkers by Different Types from 2014 to 2026

    • Table Consumption Share of Cancer Biomarkers by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Protein Biomarkers

    • Figure Market Size and Growth Rate of Genetic Biomarkers

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cancer Biomarkers by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cancer Biomarkers by Different End-Users from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Lung Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Melanoma from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Blood Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Ovarian Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

    • Figure Japan Cancer Biomarkers Market Size and Growth Rate of Liver Cancer from 2014 to 2026

    • Table Japan Cancer Biomarkers Production by Regions

    • Table Japan Cancer Biomarkers Production Share by Regions

    • Figure Japan Cancer Biomarkers Production Share by Regions in 2014

    • Figure Japan Cancer Biomarkers Production Share by Regions in 2018

    • Figure Japan Cancer Biomarkers Production Share by Regions in 2026

    • Table Japan Cancer Biomarkers Consumption by Regions

    • Table Japan Cancer Biomarkers Consumption Share by Regions

    • Figure Japan Cancer Biomarkers Consumption Share by Regions in 2014

    • Figure Japan Cancer Biomarkers Consumption Share by Regions in 2018

    • Figure Japan Cancer Biomarkers Consumption Share by Regions in 2026

    • Table Hokkaido Cancer Biomarkers Consumption by Types from 2014 to 2026

    • Table Hokkaido Cancer Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Cancer Biomarkers Consumption Share by Types in 2014

    • Figure Hokkaido Cancer Biomarkers Consumption Share by Types in 2018

    • Figure Hokkaido Cancer Biomarkers Consumption Share by Types in 2026

    • Table Hokkaido Cancer Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Cancer Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Cancer Biomarkers Consumption Share by End-Users in 2014

    • Figure Hokkaido Cancer Biomarkers Consumption Share by End-Users in 2018

    • Figure Hokkaido Cancer Biomarkers Consumption Share by End-Users in 2026

    • Table Tohoku Cancer Biomarkers Consumption by Types from 2014 to 2026

    • Table Tohoku Cancer Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Cancer Biomarkers Consumption Share by Types in 2014

    • Figure Tohoku Cancer Biomarkers Consumption Share by Types in 2018

    • Figure Tohoku Cancer Biomarkers Consumption Share by Types in 2026

    • Table Tohoku Cancer Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Tohoku Cancer Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Cancer Biomarkers Consumption Share by End-Users in 2014

    • Figure Tohoku Cancer Biomarkers Consumption Share by End-Users in 2018

    • Figure Tohoku Cancer Biomarkers Consumption Share by End-Users in 2026

    • Table Kanto Cancer Biomarkers Consumption by Types from 2014 to 2026

    • Table Kanto Cancer Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Kanto Cancer Biomarkers Consumption Share by Types in 2014

    • Figure Kanto Cancer Biomarkers Consumption Share by Types in 2018

    • Figure Kanto Cancer Biomarkers Consumption Share by Types in 2026

    • Table Kanto Cancer Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Kanto Cancer Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Cancer Biomarkers Consumption Share by End-Users in 2014

    • Figure Kanto Cancer Biomarkers Consumption Share by End-Users in 2018

    • Figure Kanto Cancer Biomarkers Consumption Share by End-Users in 2026

    • Table Chubu Cancer Biomarkers Consumption by Types from 2014 to 2026

    • Table Chubu Cancer Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Chubu Cancer Biomarkers Consumption Share by Types in 2014

    • Figure Chubu Cancer Biomarkers Consumption Share by Types in 2018

    • Figure Chubu Cancer Biomarkers Consumption Share by Types in 2026

    • Table Chubu Cancer Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Chubu Cancer Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Cancer Biomarkers Consumption Share by End-Users in 2014

    • Figure Chubu Cancer Biomarkers Consumption Share by End-Users in 2018

    • Figure Chubu Cancer Biomarkers Consumption Share by End-Users in 2026

    • Table Kinki Cancer Biomarkers Consumption by Types from 2014 to 2026

    • Table Kinki Cancer Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Kinki Cancer Biomarkers Consumption Share by Types in 2014

    • Figure Kinki Cancer Biomarkers Consumption Share by Types in 2018

    • Figure Kinki Cancer Biomarkers Consumption Share by Types in 2026

    • Table Kinki Cancer Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Kinki Cancer Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Cancer Biomarkers Consumption Share by End-Users in 2014

    • Figure Kinki Cancer Biomarkers Consumption Share by End-Users in 2018

    • Figure Kinki Cancer Biomarkers Consumption Share by End-Users in 2026

    • Table Chugoku Cancer Biomarkers Consumption by Types from 2014 to 2026

    • Table Chugoku Cancer Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Cancer Biomarkers Consumption Share by Types in 2014

    • Figure Chugoku Cancer Biomarkers Consumption Share by Types in 2018

    • Figure Chugoku Cancer Biomarkers Consumption Share by Types in 2026

    • Table Chugoku Cancer Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Chugoku Cancer Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Cancer Biomarkers Consumption Share by End-Users in 2014

    • Figure Chugoku Cancer Biomarkers Consumption Share by End-Users in 2018

    • Figure Chugoku Cancer Biomarkers Consumption Share by End-Users in 2026

    • Table Shikoku Cancer Biomarkers Consumption by Types from 2014 to 2026

    • Table Shikoku Cancer Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Cancer Biomarkers Consumption Share by Types in 2014

    • Figure Shikoku Cancer Biomarkers Consumption Share by Types in 2018

    • Figure Shikoku Cancer Biomarkers Consumption Share by Types in 2026

    • Table Shikoku Cancer Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Shikoku Cancer Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Cancer Biomarkers Consumption Share by End-Users in 2014

    • Figure Shikoku Cancer Biomarkers Consumption Share by End-Users in 2018

    • Figure Shikoku Cancer Biomarkers Consumption Share by End-Users in 2026

    • Table Kyushu Cancer Biomarkers Consumption by Types from 2014 to 2026

    • Table Kyushu Cancer Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Cancer Biomarkers Consumption Share by Types in 2014

    • Figure Kyushu Cancer Biomarkers Consumption Share by Types in 2018

    • Figure Kyushu Cancer Biomarkers Consumption Share by Types in 2026

    • Table Kyushu Cancer Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Kyushu Cancer Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Cancer Biomarkers Consumption Share by End-Users in 2014

    • Figure Kyushu Cancer Biomarkers Consumption Share by End-Users in 2018

    • Figure Kyushu Cancer Biomarkers Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Agilent Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies

    • Figure Sales and Growth Rate Analysis of Agilent Technologies

    • Figure Revenue and Market Share Analysis of Agilent Technologies

    • Table Product and Service Introduction of Agilent Technologies

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of BioMerieux SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux SA

    • Figure Sales and Growth Rate Analysis of BioMerieux SA

    • Figure Revenue and Market Share Analysis of BioMerieux SA

    • Table Product and Service Introduction of BioMerieux SA

    • Table Company Profile and Development Status of Qiagen NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen NV

    • Figure Sales and Growth Rate Analysis of Qiagen NV

    • Figure Revenue and Market Share Analysis of Qiagen NV

    • Table Product and Service Introduction of Qiagen NV

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US